“We concluded that long-term THC treatment initially has a cognition-enhancing effect by increasing energy and synaptic protein production in the brain.
Followed by an anti-aging effect by declining m TOR activity and metabolic processes in the periphery,” Bilkei-Gorzo said.
“Our study suggests that an efficient anti-aging and cognition-enhancing drug could be based on a dual effect on mTOR activity and the metabolife.”
The study has restrictions notwithstanding the encouraging outcomes. The clear one is that it is based on mice, which although helpful as models for people nevertheless have significant biological variations.
Whether others would undergo the same consequences from this kind of therapy is unknown.
Simultaneously, more study has to investigate how varying THC dosages over varying timeframes could affect the outcomes.
